Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
B. J. Thomas, S. Z. Awan, T. Joshi, M. A. Daniels, D. Porciani, D. H. Burke-Aguero
This study shows that an anti-EGFR aptamer reduces viability of NSCLC cells with EGFR L858R mutations and tumor burden in a mouse model, with cell line-dependent mechanisms.
bioRxiv · Apr 1, 2024Cancer Biology